Shares of OHR Pharmaceutical Inc (NASDAQ:OHRP) traded down 0% on Thursday . The stock traded as low as $0.24 and last traded at $0.24. 10,122 shares traded hands during mid-day trading, a decline of 99% from the average session volume of 1,238,175 shares. The stock had previously closed at $0.24.

OHR Pharmaceutical (NASDAQ:OHRP) last issued its quarterly earnings data on Tuesday, August 14th. The biotechnology company reported ($0.01) earnings per share for the quarter.

OHR Pharmaceutical Company Profile (NASDAQ:OHRP)

OHR Pharmaceutical, Inc, a clinical-stage pharmaceutical company, focuses on the development of novel therapies for the treatment of ophthalmic diseases. Its lead clinical program is topical Squalamine, a small molecule anti-angiogenic drug, which could provide a non-invasive therapy to enhance vision outcomes.

Featured Story: Trading Strategy

Receive News & Ratings for OHR Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OHR Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.